This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Novmetapharma Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Bo Bae Kim: Innovator in Diabetes Treatment
Introduction
Bo Bae Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes. His innovative approach combines various active ingredients to create effective therapeutic solutions.
Latest Patents
Bo Bae Kim holds a patent for a pharmaceutical composition aimed at preventing or treating diabetes. This composition includes a zinc salt, cyclo-hispro, and an antidiabetic drug as active ingredients. The invention focuses on utilizing a zinc cation and anion, along with cyclo-hispro or its pharmaceutically acceptable salt, combined with an insulin sensitizer, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, or a DPP-4 inhibitor.
Career Highlights
Throughout his career, Bo Bae Kim has been associated with Novmetapharma Co., Ltd., where he has contributed to the development of innovative pharmaceutical solutions. His work has been instrumental in advancing treatments for diabetes, showcasing his dedication to improving patient outcomes.
Collaborations
Bo Bae Kim has collaborated with notable colleagues, including Hoe Yune Jung and Jong Su Jeon. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic options.
Conclusion
Bo Bae Kim's contributions to diabetes treatment through his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile